Work

Prognostic significance of residual mass at the end of therapy in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study (IRS) IV experience

Year: 2005

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2005.23.16_suppl.8501

Authors: D. S. Hawkins, J. Stoner, S. Kao, D. Rodeberg, A. Hayes-Jordan, S. Qualman, S. Wolden, W. Meyer

Institutions: Seattle Children's Hospital, Mayo Clinic, Memorial Sloan Kettering Cancer Center, University of Iowa Hospitals and Clinics, University of Oklahoma Health Sciences Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2244518607

Cites:

Cited by: 2

Related to: 10